MedTrace Logo

Comparing Surgical Management Methods of Atrial Fibrillation

NCT07100483 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2026-04-13

No results posted yet for this study

Summary

Compare the efficacy of the left atrial Cox-Maze IV lesion set versus the Tampa 2 lesion set versus the EnCompass ablation alone, in the surgical treatment of atrial fibrillation at one year post-operatively.

Conditions

Interventions

PROCEDURE

Atrial Fibrillation Ablation

Ablation of the heart to reduce Afib Occurrence

Sponsors & Collaborators

  • Corewell Health West

    lead OTHER

Principal Investigators

  • Charles Willekes, MD · Corewell Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-15
Primary Completion
2027-09-15
Completion
2032-09-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07100483 on ClinicalTrials.gov